Mar 21 |
Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler
|
Mar 18 |
Chromocell appoints Frank Knuettel as CEO, removing interim status
|
Mar 18 |
Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023
|
Mar 12 |
Sidoti Events, LLC's Virtual March Small-Cap Conference
|
Feb 27 |
Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions
|
Feb 21 |
Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million
|
Feb 16 |
Chromocell stock down 11% following $7M IPO
|
Feb 16 |
Chromocell Therapeutics prices upsized $6.6M IPO at $6 per share
|
Feb 16 |
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
|